News & Updates

Use of anifrolumab improves symptoms and induces remission in patients with refractory systemic lupus erythematosus (SLE), with an acceptable safety profile, a study has shown.

Treatment of symptomatic COVID-19 with nirmatrelvir/ritonavir in children at least 6 years of age who are at risk of progression to severe disease appears to be safe and well-tolerated, with pharmacokinetic data from the open-label phase 2/3 EPIC-Peds* study indicating suitable dosing regimens for two distinct weight categories of this population.

Use of a 14-day continuous electrocardiographic monitor to screen for atrial fibrillation (AF) in older adults seen in primary care practices does not seem to result in fewer hospitalizations for stroke when compared with usual care, reports a recent study.

Moderate-to-high intakes of flavonoid result in a reduced risk of chronic obstructive pulmonary disease (COPD) and better lung function, specifically among people with a smoking history, a study has shown.